Organogenesis News

Wound Skin Substitutes Market Global Analysis to 2030, Featuring Coloplast, Smith & Nephew, MTF Biologics, MiMedx, AlloSource, Organogenesis, RTI Surgical, LifeNet Health and Molecular Biologicals

Yahoo FinanceJun 10 06:55 ET

With 38% Ownership, Organogenesis Holdings Inc. (NASDAQ:ORGO) Insiders Have a Lot Riding on the Company's Future

Yahoo FinanceJun 8 10:27 ET

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions

GlobeNewswireJun 6 16:05 ET

Does Organogenesis Holdings (NASDAQ:ORGO) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor

Simply Wall StMay 14 10:04 ET

Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating

Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating.

MT NewswiresMay 13 06:57 ET

Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceMay 12 10:05 ET

Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ...

Yahoo FinanceMay 10 15:09 ET

NVAX, GRPN and MVIS Among Mid-day Movers

Seeking AlphaMay 10 12:57 ET

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Diodes posted adjusted earnings of 28 cents

BenzingaMay 10 12:44 ET

12 Health Care Stocks Moving In Friday's Intraday Session

GainersNovavax (NASDAQ:NVAX) stock increased by 110.7% to $9.42 during Friday's regular session. The market value of their outstanding shares is at $1.3 billion. The company's, Q1 earnings came out to

BenzingaMay 10 12:31 ET

Earnings Call Summary | Organogenesis(ORGO.US) Q1 2024 Earnings Conference

The following is a summary of the Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript:Financial Performance:Organogenesis Holdings reported Q1 net revenue of $110 million, an increase

moomoo AIMay 10 11:56 ET · Conference Call

Q1 2024 Organogenesis Holdings Inc Earnings Call

Yahoo FinanceMay 10 11:49 ET

Express News | Organogenesis Shares Are Trading Higher Following Better-than-expected Q1 Earnings

BenzingaMay 10 11:11 ET

Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday

U.S. stocks were mostly higher, with the Dow Jones gaining over 100 points on Friday.

BenzingaMay 10 10:48 ET

Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript

Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 9 21:01 ET

Organogenesis (ORGO) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 9 20:45 ET

Express News | Organogenesis Reaffirms 2024 Guidance; Sees Net Revenue $445M-$470M Vs $454.69M Est

BenzingaMay 9 18:08 ET

Organogenesis Hldgs Q1 2024 Adj EPS $(0.01) Beats $(0.03) Estimate, Sales $109.976M Beat $101.050M Estimate

Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is unchanged from the same period last year

BenzingaMay 9 17:24 ET

Express News | Organogenesis Holdings Inc: Reaffirming Prior Guidance for 2024

ReutersMay 9 16:44 ET

Express News | Organogenesis Holdings Inc: Qtrly Shr Loss $0.02

ReutersMay 9 16:43 ET